I disagree, BAL have an excellent business in Australia and are looking at other markets outside of China. As we know BAL infant formula is a known brand in China and with the assistance of the Diagou plus on receipt of CFDA approval will lead to tremendous growth during the next 5 years, right now is just a short term blip in the SP which is creating another great buying opportunity.
BAL Price at posting:
$12.35 Sentiment: Buy Disclosure: Held